79 related articles for article (PubMed ID: 7160541)
1. [125I]diiodoinsulins. Binding affinities, biologic potencies, and properties of their decay products.
Pérez Maceda B; Linde S; Sonne O; Gliemann J
Diabetes; 1982 Jul; 31(7):634-40. PubMed ID: 7160541
[TBL] [Abstract][Full Text] [Related]
2. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the B-chain or 19 of the A-chain. II. Characterization of the kinetic binding constants and determination of the biological potency.
Sonne O; Linde S; Larsen TR; Gliemann J
Hoppe Seylers Z Physiol Chem; 1983 Feb; 364(2):101-10. PubMed ID: 6341199
[TBL] [Abstract][Full Text] [Related]
3. Receptor binding and biological activity of specifically labeled [125I]- and [127I]monoiodoinsulin isomers in isolated rat adipocytes.
Peavy DE; Abram JD; Frank BH; Duckworth WC
Endocrinology; 1984 May; 114(5):1818-24. PubMed ID: 6370667
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability.
Linde S; Hansen B; Sonne O; Holst JJ; Gliemann J
Diabetes; 1981 Jan; 30(1):1-8. PubMed ID: 7014299
[TBL] [Abstract][Full Text] [Related]
5. [Heterogeneity of the immunoreactivity of A14, A19, B16 and B26- (125I) monoiodoinsulin to different species of anti-insulin immuno sera].
Zhou W; Li S; Deng S
Hua Xi Yi Ke Da Xue Xue Bao; 1993 Dec; 24(4):369-72. PubMed ID: 8150434
[TBL] [Abstract][Full Text] [Related]
6. Monoiodoinsulin labelled in tyrosine residue 16 or 26 of the insulin B-chain. Preparation and characterization of some binding properties.
Linde S; Sonne O; Hansen B; Gliemann J
Hoppe Seylers Z Physiol Chem; 1981 Jun; 362(6):573-9. PubMed ID: 7024083
[TBL] [Abstract][Full Text] [Related]
7. The degradation of monoiodotyrosyl insulin isomers by insulin protease.
Ryan MP; Peavy DE; Frank BH; Duckworth WC
Endocrinology; 1984 Aug; 115(2):591-9. PubMed ID: 6378594
[TBL] [Abstract][Full Text] [Related]
8. Monoiodoinsulin specifically substituted in Tyr A14 or Tyr A19.
Linde S; Hansen B
Int J Pept Protein Res; 1980 May; 15(5):495-502. PubMed ID: 7002822
[TBL] [Abstract][Full Text] [Related]
9. A14-[125I]monoiodoinsulin purified by different high-performance liquid chromatographic procedures and by polyacrylamide gel electrophoresis: preparation, immunochemical properties and receptor binding affinity.
Benzi L; Pezzino V; Marchetti P; Gullo D; Cecchetti P; Masoni A; Vigneri R; Navalesi R
J Chromatogr; 1986 Jun; 378(2):337-47. PubMed ID: 3525587
[TBL] [Abstract][Full Text] [Related]
10. 125I-insulin metabolism by rat liver cells: preferential binding and degradation of insulin labeled at TyrA14.
Misbin RI; Buynitzky SJ; Almira EC
Drug Metab Dispos; 1982; 10(2):153-5. PubMed ID: 6124401
[TBL] [Abstract][Full Text] [Related]
11. Comparison of radiochemical purity and tissue binding of labelled insulin prepared by lactoperoxidase and chloramine T iodination.
Zórad S; Svábová E; Klimes I; Macho L
Endocrinol Exp; 1985 Dec; 19(4):267-75. PubMed ID: 3910407
[TBL] [Abstract][Full Text] [Related]
12. Effect of iodination site on binding of radiolabeled ligand by insulin antibodies and insulin autoantibodies.
Diaz JL; Wilkin TJ
Clin Chem; 1988 Feb; 34(2):356-9. PubMed ID: 2449302
[TBL] [Abstract][Full Text] [Related]
13. Receptor-mediated degradation of insulin in isolated rat adipocytes. Formation of a degradation product slightly smaller than insulin.
Sonne O
Biochim Biophys Acta; 1987 Jan; 927(1):106-11. PubMed ID: 3539208
[TBL] [Abstract][Full Text] [Related]
14. The preparation and characterization of mono-iodinated photoreactive analogs of insulin.
Heidenreich KA; Yip CC; Frank BH; Olefsky JM
Biochem Biophys Res Commun; 1985 Feb; 126(3):1138-45. PubMed ID: 3884003
[TBL] [Abstract][Full Text] [Related]
15. [Radioligand assay: methods and application. V. Mono-125I-insulin: preparation and immunological and biological characterization].
Besch W; Woltanski KP; Knospe S; Ziegler M; Keilacker H
Acta Biol Med Ger; 1980; 39(4):495-502. PubMed ID: 7004036
[TBL] [Abstract][Full Text] [Related]
16. Homogeneous mono-(125)i-insulins. Preparation and characterization of mono-(125)i-(tyr a14)-and mono-(125)i-(tyr a19)-insulin.
Jørgensen KH; Larsen UD
Diabetologia; 1980; 19(6):546-54. PubMed ID: 7007134
[TBL] [Abstract][Full Text] [Related]
17. Preparation and characterization of monoiodoinsulin.
Linde S; Hansen B
Int J Pept Protein Res; 1974; 6(3):157-63. PubMed ID: 4415172
[No Abstract] [Full Text] [Related]
18. Developing rat brain binds monoiodinated insulin isomers similarly to other extrahepatic target tissues.
Kappy MS; Clarke DW; Raizada MK; Boyd FT; Frank BH
Brain Res; 1985 Dec; 360(1-2):195-202. PubMed ID: 3907754
[TBL] [Abstract][Full Text] [Related]
19. Characterization of insulin degradation products generated in liver endosomes: in vivo and in vitro studies.
Clot JP; Janicot M; Fouque F; Desbuquois B; Haumont PY; Lederer F
Mol Cell Endocrinol; 1990 Sep; 72(3):175-85. PubMed ID: 2289630
[TBL] [Abstract][Full Text] [Related]
20. Degradation of insulin and insulin-like growth factors by enzyme purified from human erythrocytes. Comparison of degradation products observed with A14- and B26-[125I]monoiodoinsulin.
Misbin RI; Almira EC
Diabetes; 1989 Feb; 38(2):152-8. PubMed ID: 2644137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
